000 | 01199 a2200325 4500 | ||
---|---|---|---|
005 | 20250517092115.0 | ||
264 | 0 | _c20170925 | |
008 | 201709s 0 0 eng d | ||
022 | _a1558-822X | ||
024 | 7 |
_a10.1007/s11899-016-0327-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHossain, Nasheed M | |
245 | 0 | 0 |
_aT-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies. _h[electronic resource] |
260 |
_bCurrent hematologic malignancy reports _c08 2016 |
||
300 |
_a311-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntigens, Neoplasm _xgenetics |
650 | 0 | 4 | _aCell Engineering |
650 | 0 | 4 | _aCell- and Tissue-Based Therapy |
650 | 0 | 4 |
_aHLA-A2 Antigen _xmetabolism |
650 | 0 | 4 |
_aHematologic Neoplasms _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy, Adoptive |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
700 | 1 | _aChapuis, Aude G | |
700 | 1 | _aWalter, Roland B | |
773 | 0 |
_tCurrent hematologic malignancy reports _gvol. 11 _gno. 4 _gp. 311-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11899-016-0327-0 _zAvailable from publisher's website |
999 |
_c25941300 _d25941300 |